• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

bamlanivimab

Doctor holding mAb
Pharma

Use of banned antibodies remained ubiquitous this winter

The U.S. FDA earlier this year put the kibosh on a pair of monoclonal antibody combo therapies from Eli Lilly and Regeneron. Did states listen?
Fraiser Kansteiner Sep 2, 2022 9:50am
Olumiant

Lilly's Olumiant gets full FDA nod for COVID patients on oxygen

May 11, 2022 8:50am
FDA Building

With mAbs ineffective vs. subvariant, FDA limits GSK/Vir drug

Feb 24, 2022 9:35am
Lilly

Lilly wins FDA approval for yet another COVID-19 antibody drug

Feb 11, 2022 5:42pm
bamlanivimab and etesevimab Eli Lilly

Lilly scores $720M deal with U.S. for latest antibody treatment

Feb 11, 2022 8:52am
Amgen

Amgen's COVID-19 deal with Lilly helped amid drug slowdown

Feb 7, 2022 6:14pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings